Nexalin Technology, Inc. NXL
NASDAQ · United States · Health Technology
$5.73-1.82 (-24.11%)
Market closed· · USD · Data may be delayed
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-12 | -3.18 | -3.00 | -6.0% | $12.00K | -86.7% | -2.2%$10.74→$10.50 |
| Q1 2026 | 2026-05-08 | -3.30 | -3.00 | -10.0% | — | — | -1.2%$10.32→$10.20 |
| Q4 2025 | 2026-03-25 | -3.90 | -3.60 | -8.3% | — | — | -7.8%$12.24→$11.28 |
| Q3 2025 | 2025-11-14 | -3.90 | -3.60 | -8.3% | — | — | -7.7%$35.10→$32.40 |
| Q4 2024 | 2025-03-14 | -8.40 | -3.60 | -133.3% | — | — | — |
| Q3 2024 | 2024-11-08 | -6.90 | -3.60 | -91.7% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.